Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Pfizer Operating Grant in Disease Prevention and Management

University of British Columbia

$98,783.00

Preventing Diabetes with Facilitated Lifestyle Intervention Prescriptions. Phase 2: Pilot Study

EF 2011-12

Résumé
Nearly six million Canadians are living with an increased risk of diabetes (prediabetes) and approximately 50% of these will develop type 2 diabetes within five years. We wish to help these people change their lifestyle, to prevent them from getting diabetes. Trials have shown that by supporting people with prediabetes to be more active and have healthier eating habits they can halve their risk of getting diabetes. However, these trials were very costly and not performed in Canada. With the help of local Family Physicians and other health professionals (e.g. physiotherapy, psychology, endocrinology, nursing) we have created a less expensive intervention suitable for the Canadian population and health system. We need to perform a study to see whether these modified approaches are practical for Canadians and likely to be effective. People at risk will be invited by the family practices that have helped us in the initial stages of this program. These six family practices will be randomized to giving either the study intervention or continue with the physician's usual care. People receiving the intervention will have an appointment with their family doctor to discuss their exercise and eating habits and agree changes that are necessary. A prescription detailing these changes will be completed and signed by the family physician and participant. Participants will be given the name of a lifestyle change facilitator (LCF) who will receive a copy of the prescription and contact the participant to help them set achievable goals. The LCF will contact participants once a month for six months to help them achieve these goals. Our eventual aim is to test this intervention in a large-scale trial. To achieve this it is necessary to pilot all aspects of the trial. Information from this pilot study can then be used to design and perform a large-scale study effectively. We hope that eventually the numbers of Canadians progressing to having diabetes will be significantly reduced.
Programme
Pfizer Operating Grant in Disease Prevention and Management
Emplacement
British Columbia, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
240645
Name
Dawes Martin G
Region
British Columbia
Country
Canada
Orgtype
Institution Paid; Research Institution
Partnername
Pfizer Canada Inc. (Quebec)
Instname2
Health Services and Policy Research
Theme2
Health systems / services
Prcname2
Pfizer Operating Grant in Disease Prevention and Management
Projecttitle
Preventing Diabetes with Facilitated Lifestyle Intervention Prescriptions. Phase 2: Pilot Study
Programtype2
Operating Grants
Orgnameinp2
University of British Columbia
Cihramount2
$98,783
Cihrequipment2
$0
Programname2
Pfizer Operating Grant in Disease Prevention and Management
Keyworddelim
Access To Preventive Care; Behaviour Modification; Clinical Trial; Collaborative Practice; Health Promotion; Patient Self-Management Education; Pilot Study; Pre-Diabetes; Primary And Community-Based Healthcare
Abstract
Nearly six million Canadians are living with an increased risk of diabetes (prediabetes) and approximately 50% of these will develop type 2 diabetes within five years. We wish to help these people change their lifestyle, to prevent them from getting diabetes. Trials have shown that by supporting people with prediabetes to be more active and have healthier eating habits they can halve their risk of getting diabetes. However, these trials were very costly and not performed in Canada. With the help of local Family Physicians and other health professionals (e.g. physiotherapy, psychology, endocrinology, nursing) we have created a less expensive intervention suitable for the Canadian population and health system. We need to perform a study to see whether these modified approaches are practical for Canadians and likely to be effective. People at risk will be invited by the family practices that have helped us in the initial stages of this program. These six family practices will be randomized to giving either the study intervention or continue with the physician's usual care. People receiving the intervention will have an appointment with their family doctor to discuss their exercise and eating habits and agree changes that are necessary. A prescription detailing these changes will be completed and signed by the family physician and participant. Participants will be given the name of a lifestyle change facilitator (LCF) who will receive a copy of the prescription and contact the participant to help them set achievable goals. The LCF will contact participants once a month for six months to help them achieve these goals. Our eventual aim is to test this intervention in a large-scale trial. To achieve this it is necessary to pilot all aspects of the trial. Information from this pilot study can then be used to design and perform a large-scale study effectively. We hope that eventually the numbers of Canadians progressing to having diabetes will be significantly reduced.
Competitiondate
201111
Approvedterm2
1 yr 0 mth
Pinamesdelim
Dawes, Martin G
Approvedterm
1 an 0 mois
Cihrcontribution2
Patient Oriented Research~ $98,783~ $0~
University of British Columbia - $98,783 Grant (2011-… | Canada Spends